|
|
Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial
Francoise Kraeber-Bodere
,
Amandine Pallardy
,
Hervé Maisonneuve
,
Loïc Campion
,
Anne Moreau
,
et al.
Article dans une revue
hal-02425339v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Triage Scoring System Based on Early Post-Transplant Complications for Patients with Myelodysplastic Syndrome Requiring ICU after Allo-HCT: An SFGM-TC Study
Federico Garnier
,
Alain Duhamel
,
Ibrahim Yakoub-Agha
,
Alexis Caulier
,
Elodie Drumez
,
et al.
Article dans une revue
hal-03605967v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study
Karim Labreche
,
Mailys Daniau
,
Amit Sud
,
Philip J Law
,
Louis Royer-Perron
,
et al.
Article dans une revue
hal-02328989v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma
J. Biau
,
E. Thivat
,
E. Chautard
,
D. Stefan
,
Mathieu Boone
,
et al.
Article dans une revue
hal-02954534v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|